Regulatory T Cells and Tolerogenic Dendritic Cells as Critical Immune Modulators in Atherogenesis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|9|1107-1117

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.9, 2015-03, pp. : 1107-1117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macrophages and Dendritic Cells: The Usual Suspects in Atherogenesis

By  

Current Drug Targets, Vol. 16, Iss. 4, 2015-04 ,pp. : 373-382

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Modulation by Regulatory T Cells in Helicobacter pylori-Associated Diseases

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 12, Iss. 1, 2012-03 ,pp. : 71-85

Bentham Science Publishers

Access to resources Recommend Favorite

Induction of Regulatory T Cells by Dendritic Cells through Indoleamine 2,3- dioxygenase: A Potent Mechanism of Acquired Peripheral Tolerance

By  

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2234-2239

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic effect of tolerogenic dendritic cells in established collagen‐induced arthritis is associated with a reduction in Th17 responses

By  

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3656-3665

John Wiley & Sons Inc

Access to resources Recommend Favorite

HIV-Antigens Charged on Phosphorus Dendrimers as Tools for Tolerogenic Dendritic Cells-Based Immunotherapy

By  

Current Medicinal Chemistry, Vol. 21, Iss. 16, 2014-05 ,pp. : 1898-1909

Bentham Science Publishers

Access to resources Recommend Favorite